Ergebnisse der Chemotherapie des Schilddrüsenkarzinoms*

Autor:	G. Benker, D. Reinwein
Rok vydání:	2008
Předmět:	Oncology medicine.medical_specialty Chemotherapy business.industry medicine.medical_treatment Thyroid General Medicine General state medicine.anatomical_structure Tumour size Internal medicine Mean Survival Time Follicular phase medicine Doxorubicin medicine.symptom Bone pain business medicine.drug
Zdroj:	DMW - Deutsche Medizinische Wochenschrift. 108:403-406
ISSN:	1439-4413 0012-0472
DOI:	10.1055/s-2008-1069567
Popis:	Doxorubicin chemotherapy was performed in 52 patients with thyroid malignancies. Data from 47 patients could be evaluated. 16 remissions and partial remissions were seen, 15 cases had a progressive course, and in 16 patients there was no change of tumour size during the period of treatment. Results of treatment were worse in locally invasive tumour growth and reduced general state of health as well as in anaplastic carcinomas. Results were best in follicular and C-cell carcinomas. The mean survival time of patients responding to treatment was longer than in non-responders. The main indication for treatment is alleviation of tumour symptoms (bone pain, threatening fractures, pressure due to tumour); further indications are anaplastic carcinomas because of their bad prognosis and C-cell carcinomas because of their comparatively satisfactory response.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::169fbe2ccacfc363006acd12ae80a852 https://doi.org/10.1055/s-2008-1069567 Zobrazit plný text záznamu